All News

Study results establish LAG-3 inhibition as therapeutically relevant third immune checkpoint pathway

Additionally, the study showed a 15-fold increase in maternal mortality rates associated with chronic hypertension over the 40-year study period.

New study results show that though men are more likely to have heart conditions, the impact on their memory and thinking skills is lower.

Similasan Earache Relief drops are recommended for earache discomfort, clogged ears, and trapped water.

Results of an analysis from the University of Eastern Finland show that supplementation for 5 years had no effect on total mortality or the incidence of these diseases in older individuals.

The recommendations include full immunization, including third doses and/or any approved boosters.

Alyson McGregor, MD, of Brown University explains what pharmacists should understand about the impact of sex and gender on medicine within their practice.

Breo Ellipta is indicated for long-term, once-daily, maintenance treatment of airflow obstruction and reducing exacerbations in patients with chronic obstructive pulmonary disease.

Dupilumab has been a breakthrough treatment for patients with atopic dermatitis, but future studies are needed to continue learning about its strength.

Proof-of-contest is inexpensive and quantifies specific antigens from a drop of blood within minutes.

Patients with EGFR exon 20 insertion mutation NSCLC account for approximately 1%-2% of NSCLC cases.

This will be the third collaboration between Pfizer and BioNTech in the infectious diseases field, following the influenza vaccine collaboration in 2018 and the COVID-19 vaccine collaboration in 2020.

There were no instances of participants withdrawing from the study due to an adverse event caused by psilocybin in the treatment of mental health conditions.

GeneSight Mental Health Monitor finds that many struggle to know the difference between teenage behavior and a mental health challenge.

Results of a separate analysis demonstrate that Johnson & Johnson’s booster generated a 41-fold increase in neutralizing antibodies and a 5-fold increase in T-cells against omicron.

The drug is made from Ananda’s Liquid Structure technology that creates new potential for cannabidiol therapeutics, such as facilitating voluntary opioid sparing.

Alyson McGregor, MD, of Brown University explains what pharmacists can do to advance issues arising around the impact of sex and gender on medicine.

Xlear treats sinus pressure and congestion caused by colds, flu, allergies, pollen, and post-nasal drip.

Anifrolumab-fnia is a human immunoglobulin G (IgG)1κ monoclonal antibody indicated for the treatment of moderate to severe systemic lupus erythematosus.

Generalized anxiety disorder has symptoms that are similar to panic disorder, obsessive-compulsive disorder, and other types of anxiety.

Abby Sauer, a registered dietitian specializing in adult nutrition at Abbott, discusses how the unique nutritional needs of women evolve with age and some tips pharmacists can provide to women 30 years of age and older in the pharmacy.

The submission is supported by data from MajesTEC-1, a multicenter clinical trial evaluating the safety and efficacy of teclistamab in adults with RRMM.

In laboratory molecular tests, scientists mix samples with assay reagents in a highly controlled process, but because the reaction conditions are tightly controlled, the tests are both sensitive and selective, according to the researchers.

Pay for outcomes is here to stay, but are pharmacy claims an outdated source of quality measurement?

These lumps can relate to the overproduction of hormones, including the stress steroid hormone cortisol, which can lead to T2D and high blood pressure.

Rebecca Sleeper, PharmD, FCCP, FASCP, BCPS, of the Texas Tech University Health Sciences Center Jerry H. Hodge School of Pharmacy, discusses how a lack of sex and gender specific patient care education can impact a pharmacist’s work with their patients.

In the first quarter of 2022, Genprex expects to initiate its Acclaim-2 clinical trial to evaluate the treatment for individuals with histologically confirmed unresectable stage III or IV non–small cell lung cancer.

Tixagevimab co-packaged with cilgavimab is one of the only 2 antibody therapies issued emergency use authorization by the FDA that showed neutralizing activity against omicron and all other variants of concern.